NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $8,912,000 | +40.3% | 1,148,396 | +39.3% | 0.12% | +40.0% |
| Q4 2014 | $6,354,000 | +50.7% | 824,182 | +41.3% | 0.08% | +46.6% |
| Q3 2014 | $4,217,000 | +58.8% | 583,254 | +71.6% | 0.06% | +56.8% |
| Q2 2014 | $2,655,000 | +342.5% | 339,888 | +341.0% | 0.04% | +311.1% |
| Q1 2014 | $600,000 | – | 77,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|